Study Title

LCCC 1917: Dose Escalation of Low and Intermediate Risk Localized Prostate Cancer Using 68Ga-HBED-CC PSMA-PET/MRI and Stereotactic Body Radiotherapy

Study Details

Description:

The goal of this study is to determine the safety of using PSMA-PET/mpMRI to define radiotherapy targets, while meeting all current planning criteria. This study also intends to determine the feasibility of performing stereotactic body radiation therapy with simultaneous integrated boost on the dominant intra-prostatic lesions while meeting all current planning criteria.

Sponsor:

UNC Lineberger Comprehensive Cancer Center

Contacts:

Panayiotis Mavroidis, PhD

panayiotis_mavroidis@med.unc.edu

984-974-8438

Sarah Gadre

sarah_gadre@med.unc.edu

984-215-5425

© 2021 XCancer Software LLC

Contact XCancer: 402-991-8468